MNPR Earnings Monopar Therapeutics
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -0.46 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -1.85 | 2026-03-27 | 10-K |
| Q3 2025 | 2025-09-30 | -1.21 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.73 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.38 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -4.11 | 2026-03-27 | 10-K |
| Q3 2025 | 2024-09-30 | -1.36 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.00 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.51 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -3.04 | 2025-03-31 | 10-K |
| Q3 2024 | 2023-09-30 | -2.43 | 2024-11-08 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.35 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.19 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -0.83 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -0.60 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.41 | 2023-08-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.